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Abstract
Stromal cell-derived factor-1 (SDF-1) and its receptor CXC chemokine receptor 4 (CXCR4) are
important regulators of the development of the dentate gyrus (DG). Both SDF-1 and CXCR4 are also
highly expressed in the adult DG. We observed that CXCR4 receptors were expressed by dividing
neural progenitor cells located in the subgranular zone (SGZ) as well as their derivatives including
doublecortin-expressing neuroblasts and immature granule cells. SDF-1 was located in DG neurons
and in endothelial cells associated with DG blood vessels. SDF-1-expressing neurons included
parvalbumin-containing GABAergic interneurons known as basket cells. Using transgenic mice
expressing an SDF-1-mRFP1 (monomeric red fluorescence protein 1) fusion protein we observed
that SDF-1 was localized in synaptic vesicles in the terminals of basket cells together with GABA-
containing vesicles. These terminals were often observed to be in close proximity to dividing nestin-
expressing neural progenitors in the SGZ. Electrophysiological recordings from slices of the DG
demonstrated that neural progenitors received both tonic and phasic GABAergic inputs and that
SDF-1 enhanced GABAergic transmission, probably by a postsynaptic mechanism. We also
demonstrated that, like GABA, SDF-1 was tonically released in the DG and that GABAergic
transmission was partially dependent on coreleased SDF-1. These data demonstrate that SDF-1 plays
a novel role as a neurotransmitter in the DG and regulates the strength of GABAergic inputs to the
pool of dividing neural progenitors. Hence, SDF-1/CXCR4 signaling is likely to be an important
regulator of adult neurogenesis in the DG.
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Introduction
Neural stem cells residing in the subgranular zone (SGZ) of the adult hippocampal dentate
gyrus (DG) generate new granule neurons throughout life (Kempermann et al., 2004; Zhao et
al., 2006). However, little is known about the physiological mechanisms that normally regulate
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this process. The initial development of DG neural stem cells is thought to occur in a specialized
neurovascular niche in which the cells are exposed to both blood born and neuronally released
regulatory influences (Palmer et al., 2000). Indeed, numerous substances have been shown to
alter the rate or extent of DG neurogenesis (Sohur et al., 2006). One important question is how
the granule cell layer, and neuronal activity in general, instructs the pool of developing neural
progenitors to increase or decrease the extent of neurogenesis, a process known as “excitation–
neurogenesis coupling” (Deisseroth and Malenka, 2005). To this end, it has been demonstrated
that neural progenitors initially receive GABAergic inputs and that activation of GABAA
receptors expressed by neural progenitors can influence their proliferation and subsequent
development (Tozuka et al., 2005; Ge et al., 2006). The source of GABA that influences DG
neural progenitor function is not precisely known, although it has been suggested that it may
be derived from DG interneurons such as basket or axo-axonic cells (Tozuka et al., 2005). DG
neural progenitors are initially subject to tonically released GABA and subsequently develop
phasic synaptic GABAergic inputs (Tozuka et al., 2005; Ge et al., 2006). As with many
immature neurons, these early GABAergic influences generally serve to depolarize DG neural
progenitors (Tozuka et al., 2005; Ge et al., 2006). It is thought that GABA-mediated
depolarization results in the influx of Ca2+ which then regulates progenitor cell proliferation
and development.
The chemokines are a family of small proteins that have been widely studied because of their
key role in orchestrating the migration of leukocytes during inflammatory responses. In
addition, signaling by the chemokine stromal cell-derived factor-1 (SDF-1; also known as
CXCL12) via its receptor CXC chemokine receptor 4 (CXCR4) has been shown to be of great
importance in the development of many tissues including the nervous system (Tran and Miller,
2003). In particular, SDF-1/CXCR4 signaling is of key importance in the initial development
of the DG (Bagri et al., 2002; Lu et al., 2002). During development, SDF-1 expressed by the
meninges provides a chemotactic cue for neural progenitors migrating from the lateral ventricle
to the nascent DG. SDF-1 also regulates the proliferation of these cells. Interestingly, CXCR4
and SDF-1 are both extensively expressed in the adult DG (Stumm et al., 2002; Tran et al.,
2007), suggesting that they may continue to exert an important influence on neurogenesis. We
now demonstrate that SDF-1 is localized to nerve terminals of DG neurons and that tonic release
of SDF-1 regulates GABAergic inputs to DG neural progenitors. These results suggest that
SDF-1 can act as a neurotransmitter and that SDF-1/CXCR4 signaling may contribute to the
regulation of neurogenesis in the DG.
Materials and Methods
Animals
The transgenic mice used in this study were nestin-enhanced green fluorescent protein (EGFP)
(nestinenhancer::EGFP) (Tran et al., 2007) (kindly provided by Anjen Chenn, Northwestern
University) and the following bacterial artificial chromosome (BAC) transgenic mice:
CXCR4-EGFP (CXCR4BAC::EGFP), SDF-1-EGFP (SDF-1BAC::EGFP), and doublecortin
(DCX)-EGFP (DCXBAC::EGFP) [kindly provided by Dr. Mary Beth Hatten (The Rockefeller
University, New York, NY) and The Gene Expression Nervous System Atlas (GENSAT)
project, National Institute of Neurological Disorders and Stroke contract N01Nso2331 to The
Rockefeller University, New York, NY (http://www.gensat.org)]. All animal-related
procedures were approved by the Northwestern University animal care and use committee.
Generation of SDF-1-mRFP1 BAC transgenic mice (SDF-1BAC::SDF-1-mRFP1)
The SDF-1-containing BAC clone (RP23–203H21; the same clone that was used to generate
SDF-1-EGFP mice by the GENSAT) was obtained from Invitrogen. To generate SDF-1-BAC
reporter vector, monomeric red fluorescence protein 1 (mRFP1) was inserted at the end of the
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SDF-1α coding sequence by λ-Red-mediated recombination with slight modifications (Lee et
al., 2001). The mRFP1-FRT-KAN-FRT targeting cassette was generated by self-ligation of
blunt-ended BglII-SmaI fragment of pIGCN21 and then replacing the EGFP coding sequence
with that of mRFP1 (Lee et al., 2001). The targeting cassette was amplified by PCR using the
following chimeric primers, 3′ of which were homologous to targeting cassette and 5′ of which
were homologous to the last exon of SDF-1α: for upstream, 5′-
CATTGACCCGAAATTAAAGTGGATCCAAGAGTACCTGGAGAAAGCTTTAAACA
AGCCGGTCGCCACCATGGCCTCC-3′; for downstream, 5′-
CACTGCCCTTGCATCTCCCACGGATGTCAGCCTTCCTCGGGGGTCTACTGGAAA
GCTATTCCAGAAGTAGTGAGGA-3. The primers were designed to target mRFP1
immediately downstream of CCR2 coding sequence and upstream of poly (A) site. The stop
codon of SDF-1α was deleted to generate SDF-1-mRFP1 fusion construct. In this way, the
splicing sites for SDF-1β and SDF-1γ were disrupted, so SDF-1α-mRFP1 would be expressed
in any cell where any isoforms of SDF-1 are expressed. Transgenic mice were generated by
the Center for Genetic Medicine, Northwestern University.
Histology and immunohistochemistry
Mice (3 to 5 weeks old) were anesthetized and perfused transcardially with cold PBS, followed
by a freshly prepared solution of 4% paraformaldehyde (PFA) in PBS, pH 7.4. The brains were
rapidly removed and postfixed overnight in 4% PFA at 4°C. Forty-micrometer-thick coronal
sections were cut with a vibratome (Leica VT 1000S) and collected in cold PBS. Sections were
then processed for histology or immunohistochemistry.
Immunohistochemistry was performed on free-floating sections using the following primary
antibodies: Ki67 (1:200; BD Biosceinces PharMingen), bromodeoxyuridine (BrdU; 1:500;
Fitzgerald), parvalbumin (1: 500; Swant), BrdU antibody (Fitzgerald), vesicular GABA
transporter (VGAT; 1:200; Synaptic Systems), synaptotagmin 1 (1:400; Synaptic Systems),
synaptoporin (1:400; Synaptic Systems), synaptic vesicle protein 2 (SV2; 1:400; Synaptic
Systems), and bassoon (1:400, Assay Designs). The appropriate isotype-specific secondary
antibodies consisted of Alex-aFluor 633-conjugated preparations (1:400; Invitrogen).
Sections were incubated in PBS/10% normal serum of a host where the secondary antibody
was raised/0.5% Triton X-100 for 90 min at room temperature (RT). They were then incubated
with primary antibodies diluted in PBS/3% normal serum/0.1% Triton X-100, 24 h at 4°C. The
sections were then washed with PBS and incubated with secondary antibodies diluted in PBS/
1% normal serum for 1 h. Sections were washed with PBS, mounted on slides, and analyzed
by a confocal microscopy.
For the staining of blood vessels, tomato lectin (from Lycopersicon esculentum) conjugated to
FITC (Vector Laboratories) was allowed to circulate for 5 min before the animals were perfused
with 4% PFA.
BrdU labeling
Adult mice received intraperitoneal injections of BrdU [Sigma-Aldrich; 50 mg/kg body weight;
dissolved in sterile PBS (10 mg/ml) and filtered at 0.22 µm]. To label dividing cells in the adult
brain, mice were given three injections separated by 2 h. Twenty-four hours after the first
injection, animals were anesthetized and perfused transcardially with PBS, followed by a
freshly prepared solution of 4% PFA in PBS, pH 7.4. The brains were rapidly removed and
postfixed overnight in 4% PFA at 4°C. Forty-micrometer-thick coronal free-floating sections
were cut with a vibratome (Leica VT 1000S) and collected in cold PBS. Brain sections were
incubated for 20 min in 2N HCl at 37°C before subjected to immunohistochemistry.
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Plasmid construction and adenovirus production
SDF-1-mRFP1 was made by cloning PCR fragment of SDF-1 protein coding sequence into
pmRFP1-N1 (a kind gift from Dr. Roger Tsien, University of California, San Diego, La Jolla,
CA). Sequence identity was confirmed by dideoxy-sequencing methods. To make
adenoviruses, the fragments containing promoter, protein coding sequence, and poly-A signal
were cloned into pShuttle vector and adenovirus was generated using AdEasy system (He et
al. 1998). Chemicals were purchased from Sigma-Aldrich unless stated otherwise.
Cell culture and transfection
F11 [a neuronal cell line derived from dorsal root ganglion (DRG) neurons] (Francel et al.,
1987) cells were maintained in DMEM supplemented with 10% fetal bovine serum (FBS),
0.5% penicillin–streptomycin (P/S) at 37°C under 5% CO2. One microgram of plasmid DNA
was transfected using Mirus-LT1 according to the manufacturer’s instructions. To induce
differentiation of F11 cells, the medium was changed toDMEM supplemented with 0.5% FBS,
0.5% P/S, and 0.5 mM dibutyryl-cAMP 24 h after the transfection. Cells were incubated for
48–72 h to induce differentiation. Materials for cell culture were purchased from Invitrogen
unless stated otherwise.
DRG neuronal culture and adenoviral transduction
Mouse dorsal root DRG neurons were prepared as described previously with slight
modifications (Jung et al., 2008). Cells were plated on poly-L-lysine (BD Biosciences)- and
laminin (BD Biosciences)-coated coverslips and incubated in F12 supplemented with 0.5%
FBS, 1% N2, 50 ng/ml NGF, and 0.5% P/S. On the next day, 10 µM cytosine arabinoside was
added to eliminate mitotic cells including ganglionic fibroblasts. Medium was replaced every
2–3 d. Cultures were maintained at 37°C with 5% CO2 for up to 2 weeks. After 3–5 d in culture,
DRG neurons were infected with adenovirus expressing SDF-1-mRFP1 with 50–100
multiplicity of infection and used in 3–5 d.
Hippocampal slice preparation
Hippocampal slices were prepared from 3- to 4-week-old nestin-EGFP or DCX-EGFP mice.
Animals were deeply anesthetized and then decapitated. The brains were removed quickly and
placed into ice-cold cutting solution of the following composition (in mM): 234 sucrose, 28
NaHCO3, 2.5 KCl, 1.25 NaH2PO4, 0.5 CaCl2, 7 MgCl2, 7 glucose, 1 ascorbic acid, and 3
pyruvic acid, saturated with 95%O2/5%CO2 atpH7.4. For each experiment, coronal sections
of dentate gyrus (300 µm) were obtained with a vibratome and kept for 30 min at 37°C in
oxygenated standard artificial CSF (ACSF) (in mM): 130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25
NaH2PO4, 1.5 CaCl2, 1 MgSO4, and 10 glucose, saturated with 95% O2/5% CO2 at pH 7.4.
Slices were stored in modified interface chamber for 30–40 min at 37°C and then maintained
at room temperature until being transferred to the recording chamber in oxygenated standard
ACSF containing (in mM) 130 NaCl, 24 NaHCO3, 3.5 KCl, 1.25 NaH2PO4, 1.5 CaCl2, 1
MgSO4, and 10 glucose, saturated with 95% O2 and 5% CO2 at pH 7.4. The GFP-positive cells
were observed with the aid of a fluorescence microscope (BX-50WI; Olympus) and visualized
with a chilled charge-coupled device video camera (Dage-MTI) with a 40× water-immersion
differential interference contrast objective. After identification of the GFP signals, the light
path of the microscope was switched to the infrared differential interference contrast (infrared
DIC) optics mode. Infrared DIC images were monitored on a video monitor, which helped for
visual guidance of the patch electrode, for morphological analyses and identification of the
location of the recorded neuron. All experiments performed here were performed in accordance
with animal experimentation protocols approved by the National Institutes of Health and
institutional protocols.
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Electrophysiological recordings
Whole-cell patch-clamp recordings were performed from GFP+ cells located in the subgranular
zone (hilar region) and ~10–20 µm below the surface of the slice of hippocampus as described.
Type 2 cells were identified by their GFP-labeled cell body, shape with poorly developed
processes, and high input resistance (IR) value (>0.5 GΩ). Differential interference contrast
and fluorescent images were combined for simultaneous viewing of GFP-labeled and-
unlabeled cells.
For whole-cell recordings, patch electrodes with a resistance of 5–7 MΩ were pulled from
borosilicate capillaries (World Precision Instruments; PG52165-glass) using a P-97 pipette
puller (Sutter Instrument). Patch pipettes were filled with a solution that mimicked the
intracellular environment and that contained (in mM) 150 KCl, 10 HEPES, 4Mg2ATP, 0.5
NaGTP, and 10 phosphocreatine. The pH was adjusted to 7.3 with KOH. The IR and resting
membrane potential were measured from each cell. No compensation was made for liquid
junction potentials. Whole-cell voltage-clamped recordings were obtained from the
fluorescence-labeled cells using an Axopatch 200B patch-clamp amplifier (Molecular
Devices) and the data were captured with pClamp 9.0 software (Molecular Devices). Series
resistance (8–25 MΩ) was monitored, and experiments were discarded if substantial changes
were observed. SDF-1α (BD Biosciences), AMD3100, bicuculline methiodide, 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX), dl-2-amino-phosphonovaleric acid (APV), tetrodotoxin
(TTX), and CdCl2 were applied by either focal or bath application. Cells were clamped at −70
mV and recording was obtained in presence of 10 µM CNQX and 50 µM APV. After the recording
session, the patch electrode was carefully removed from the cell, and the pipette tip
fluorescence was checked to make sure GFP-positive cells are patched.
Data analysis
Data were filtered at 2 kHz and digitized at 10 kHz using a Digidata 1322A analog-to-digital
board. Analysis was performed using the pClamp 9.0 (Molecular Devices), MiniAnalysis
(Synaptosoft), Sigmaplot (Systat), Igor Pro 5.02 (Wavemetrics), and Prism (GraphPad)
software packages. For tonic current measurement, Igor Pro 5.02 was used to load the digitized
recording and in this method, the baseline was calculated by generating all-point histograms
of 10 s epochs at control and drug-treated conditions (Nusser and Mody, 2002). A Gaussian
distribution was fitted to the positive side of the all-point histograms and the differences
between the means of the fitted Gaussians were then calculated.
For the detection and measurement of PSCs: all PSCs were detected in 1 to 3 min recording
segments under the appropriate experimental configuration (baseline control, drug
application). Event frequency and amplitude were determined by MiniAnalysis software
(Synaptosoft).
SDF-1 release and ELISA
Hippocampi were dissected from postnatal day 14 mice and digested with papain at 37°C for
20 min. After trituration, granule cell fraction was purified by Percoll gradient centrifugation
(60% Percoll, 30% Percoll, and cell suspension from bottom to top layers; centrifugation at
8000 × g for 15 min; granule cell fraction isolated from the middle layer). Granule cell-enriched
fraction was plated on poly-D-lysine treated 12-well plates in Neurobasal medium (Invitrogen)
containing 2 mM L-glutamine, 1× B-27, and 1× N2 supplements. After 2 d in culture, a sandwich
ELISA for SDF-1 was performed. Cells were washed with a balanced salt solution (BSS)
containing (in mM) 140 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, and 10 glucose, pH 7.4. And then
cells were incubated with normal BSS or with high-potassium BSS containing (in mM) 95 NaCl,
50 KCl, 2 CaCl2, 1 MgCl2, 10 and glucose, pH 7.4, for 1 h. Supernatant was centrifuged again
at 3000 × g for 5 min to exclude possible contamination of floating cells. SDF-1 in the
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supernatant was measured by a standard sandwich ELISA. Briefly, a 96-well plate was coated
with a capture antibody (goat polyclonal anti-SDF-1 antibody, 1:200, C-19; Santa Cruz
Biotechnology) in carbonate-bicarbonate buffer, pH 9.7, at 4°C overnight. After blocking with
10% normal donkey serum in PBS containing 0.05% Tween-20 (PBS-T) for 2 h at RT, samples
were added to the wells and the plate was incubated for 6 h at RT. After washing (five times
with PBS-T), a detection antibody (mouse monoclonal anti-SDF-1 antibody, 1:1000, P-159X;
Santa Cruz Biotechnology) diluted in the blocking solution was added and the plate was
incubated at 4°C overnight. After washing, a secondary antibody (donkey anti-mouse-IgG-
HRP; 1:10,000; Santa Cruz Biotechnology) was added. After 2 h, the plate was washed and
TMB-One (Promega) was added. After 10 min, the reaction was stopped by 1 N HCl and
OD450 was measured. A standard curve was obtained by total cell lysate diluted serially in
BSS, and release was expressed as a percentage of cell contents.
Statistical analysis
Values are given as mean ± SEM. Statistical comparisons were performed by unpaired
Student’s t test (supplemental Fig. 2d, available at www.jneurosci.org as supplemental
material) or by one-way ANOVA followed by Bonferroni’s post hoc multiple-comparison test
(the rest of the figures). p < 0.05 was considered statistically significant. The Kolmogorov–
Smirnov two-sample, two-tailed test was used to compare the amplitude distribution of the
phasic currents.
Results
To investigate the functions of SDF-1/CXCR4 signaling in the DG of young mice, we made
use of different types of EGFP BAC reporter mice. The characteristics of these mice have been
described previously (http://www.gensat.org) (Tran et al., 2007). In particular, it has been
demonstrated that the expression of EGFP in the brains of the SDF-1 and CXCR4 reporter
mice closely resembles that observed using in situ hybridization, and that several lines of the
transgenic mice generated by the same BAC clones showed consistent expression patterns
(http://www. gensat.org). Therefore, EGFP expression faithfully represents the cellular
localization of SDF-1 and CXCR4 expression in these mice.
It has been demonstrated previously that SDF-1/CXCR4 signaling is essential for the migration
and proliferation of the neural stem cells that form the DG during its initial development (Bagri
et al., 2002; Lu et al., 2002). However, both CXCR4 and its ligand, the chemokine SDF-1, are
extensively expressed in the DG of adult mice, particularly in the SGZ (Tran et al., 2007) (Fig.
1a,b). To understand the functions of CXCR4 signaling in the DG of young mice, we wished
to determine the precise cellular localization of these molecules. Previous studies have
suggested that CXCR4 is expressed by neural stem cells in the DG as well as their progeny,
which include the early stages of granule cell development (Tran et al., 2007). To further test
this hypothesis, we isolated nestin-EGFP- (Fig. 1c) and DCX-EGFP-expressing (Fig. 1d) cells
from reporter mice by fluorescence-activated cell sorting (FACS) and found that they expressed
high levels of CXCR4 receptor mRNA (Fig. 1e,f ). Cells isolated in this manner also stained
with an antibody against CXCR4 receptors (data not shown). Because nestin and DCX are
expressed by neural progenitors and migrating neuroblasts, respectively (Kempermann et al.,
2004), this indicates that CXCR4 is expressed by DG neural progenitors during the early stages
of their development. We also labeled dividing cells in the DG by administering BrdU to
CXCR4-EGFP BAC reporter mice and localized BrdU using immunohistochemistry. We
observed that CXCR4-EGFP cells in the SGZ frequently incorporated BrdU, further indicating
that they were actively proliferating (Fig. 1g). These data demonstrate that CXCR4-expressing
cells in the SGZ include a population of dividing neural progenitors, suggesting that CXCR4
signaling may continue to play a role in their development.
Bhattacharyya et al. Page 6













The ligand for CXCR4 receptors is the chemokine SDF-1. During development of the DG,
SDF-1 is highly expressed in the meninges (Lu et al., 2002). However, examination of the
distribution of SDF-1 in the DG of 4-week-old animals using SDF-1-EGFP BAC reporter mice
(Fig. 1b), immunohistochemistry, or in situ hybridization (Stumm et al., 2002; Banisadr et al.,
2003; Miller et al., 2005; Tran et al., 2007) suggests that it is subsequently expressed in DG
neurons. Chemokines are well known to be important regulators of leukocyte trafficking.
However, what is the significance of a chemokine expressed by a neuron? We have observed
that expression of fluorescent chemokine reporter fusion proteins, including monocyte
chemotactic protein-1 (MCP-1)/CCL2 and SDF-1-mRFP1 or EGFP, in cultured neurons results
in their processing by the Golgi apparatus and subsequent packaging into synaptic vesicles
localized in neurites (Jung et al., 2008) (supplemental Fig. 1a,b, available at
www. jneurosci.org as supplemental material). These vesicles can be released from DRG
neurons in a depolarization and Ca-dependent manner (Jung et al., 2008) (H. Jung and R. J.
Miller, unpublished observations). Both endogenous chemokines and chemokines tagged with
fluorescent proteins are targeted to vesicles and released by depolarization. In contrast, when
EGFP or mRFP1 are expressed in these same neurons, they show a pattern in which they are
not localized to vesicles and fill the entire cell (supplemental Fig. 1c, available at
www.jneurosci. org as supplemental material). These proteins are also not released by
depolarization. Such observations suggest that the normal distribution and release of
chemokines is not altered by modification with fluorescent protein tags (Jung et al., 2008),
something that is also true with other small proteins such as growth factors when they are
tagged and expressed in neurons (Egan et al., 2003; Shakiryanova et al., 2006). Because of its
neuronal localization in the DG of young mice, we hypothesized that SDF-1 might act as a
neurotransmitter.
To examine the precise subcellular localization of SDF-1 in the DG, we made a BAC transgenic
mouse line in which mRFP1 was fused to the C terminus SDF-1. In these mice, mRFP1 was
inserted immediately upstream of the SDF-1α termination codon using the same BAC clone
used to generate the SDF-1-EGFP reporter mice discussed above, whose specificity was
confirmed by the similar expression patterns observed in different lines of transgenic mice
made from this BAC clone (http://www. gensat.org). Cells in which endogenous signaling
drives the expression of SDF-1 will make the SDF-1-mRFP1 fusion protein in addition to the
normal endogenous isoform of SDF-1. Because there are no known cleavage sites in the C
terminus, SDF-1-mRFP1 is expected to be a good marker for intracellular localization of
endogenous SDF-1. Using these mice, we observed that SDF-1-mRFP1 was expressed in cell
types where it would normally be expected, based on previous studies (supplemental Fig. 1d–
j, available at www.jneurosci. org as supplemental material). This includes endothelial cells
associated with blood vessels, the bone marrow, and different types of neurons, such as those
in the hippocampus and cerebellum (Stumm et al., 2002; Banisadr et al., 2003; Miller et al.,
2005; Sugiyama et al., 2006) (Fig. 2a; supplemental Fig. 1d–j, available at
www.jneurosci.org as supplemental material). Although the same BAC clone was used to make
the EGFP reporter mouse and the SDF-1-mRFP1 mouse, and the general cellular expression
pattern of the two fluorescent molecules was very similar, the subcellular distribution of EGFP
and mRFP1 was quite different. In the SDF-1-EGFP reporter mouse, freely diffusible EGFP
filled the entire cell including the cell body and neurites (Fig. 1b). However, as we predicted,
expression of SDF-1-mRFP1 in neurons was restricted to vesicle like structures, many of which
were localized in cell processes. In the hippocampus, punctate structures expressing SDF-1-
mRFP1 were observed to be widely distributed in areas including the hilus, molecular layer
and SGZ of the DG (Fig. 2a). Appropriately, this is an identical distribution pattern to that
observed using immunohistochemistry to detect endogenous SDF-1 (Miller et al., 2005) Three
types of signals were readily distinguishable (Fig. 2a). First SDF-1-mRFP1-expressing vesicles
were aligned with small tube-like structures which proved to be blood vessels, as they could
be labeled by perfusion with tomato lectin (Fig. 2a,b). Second, SDF-1-mRFP1-expressing
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vesicles were observed within the cell bodies of some neurons (Fig. 2a,c), and third, terminal
like structures containing SDF-1-mRFP1-expressing vesicles were localized around numerous
cell bodies (Fig. 2a). We noted that some of the neurons that contained SDF-1-mRFP1-
expressing vesicles had the general morphology of basket cells, a major type of DG interneuron
(Blasco-Ibáñez et al., 2000). Indeed, these particular SDF-1-mRFP1-expressing cells also
expressed parvalbumin, a marker for some types of DG basket cells (Fig. 2a,c). To precisely
determine the relative juxtaposition of sites of CXCR4 and SDF-1 expression, we generated
reporter mice which expressed both SDF-1-mRFP1 (red) and CXCR4-EGFP (green)
(supplemental Fig. 1d–j, available at www.jneurosci.org as supplemental material). We
observed that SDF-1-mRFP1-labeled vesicles in parvalbumin positive neurons were often
localized in the vicinity of CXCR4-expressing cells in the SGZ, which had the morphology of
neural progenitors (Fig. 3a–c, supplemental Fig. 2a–c, available at www.jneurosci.org as
supplemental material). Furthermore, SDF-1-mRFP1-labeled vesicles were also localized in
close proximity to dividing cells labeled with BrdU or Ki67 in the SGZ (Fig. 2d,e). We also
prepared SDF-1-mRFP1 (red)/nestin-EGFP (green) and SDF-1-mRFP1 (red)/DCX-EGFP
(green) mice, and observed that SDF-1-expressing vesicles were associated with most nestin-
expressing cells and many DCX-expressing cells (Fig. 3d–f, supplemental Fig. 2a–c, available
at www.jneurosci. org as supplemental material). SDF-1-mRFP1-labeled vesicles were
observed in close juxtaposition to nestin-EGFP-expressing “type 2” cells and DCX-EGFP-
expressing cells with an immature morphology exhibiting a round shape and few processes
(Fig. 3d–f, supplemental Fig. 2b,c, available at www.jneurosci.org as supplemental material).
Because SDF-1-mRFP1 was expressed in presumed GABAergic basket cells we also examined
the relative expression pattern of SDF-1 and VGAT, the high-affinity amino acid transporter
expressed by GABA-containing synaptic vesicles. Interestingly, SDF-1- and VGAT-labeled
vesicles were often localized to the same basket cell nerve terminals in the SGZ. SDF-1/GABA-
labeled terminals were frequently observed in close juxtaposition to CXCR4-expressing cells
with neural progenitor morphology or with nestin-EGFP or DCX-EGFP-expressing cells (Fig.
3, supplemental Fig. 2a–c, available at www. jneurosci.org as supplemental material).
Interestingly, however, the basket cells themselves did not express CXCR4 receptors
(supplemental Fig. 2a, available at www.jneurosci.org as supplemental material). Moreover,
SDF-1-mRFP1 expressed in endothelial cells in blood vessels was not colocalized with GABA
(Fig. 3). Overall, these data suggest that some of the SDF-1 in the DG is localized to GABA-
containing synaptic terminals in parvalbumin-expressing basket cells and that these terminals
are localized in close proximity to proliferating CXCR4-expressing neural progenitors in the
SGZ. It should also be pointed out that, as discussed above, SDF-1-mRFP1 is localized to
numerous punctate structures throughout the hippocampus and the majority of these are
presumably not associated with basket cells.
The identity of the SDF-1-mRFP1-containing vesicles was further determined by costaining
sections from the DG of SDF-1-mRFP1/CXCR4-EGFP mice with antibodies for different
markers for synaptic vesicles and nerve terminals. We observed that SDF-1-mRFP1-containing
vesicles situated in close proximity to CXCR4-EGFP-expressing cells in the SGZ frequently
stained with antibodies against synaptotagmin-1, synaptoporin, or SV2, which are all known
to be associated with transmitter-containing synaptic vesicles (Jinno and Kosaka, 2003;
Khanna et al., 2007; Leitzell, 2007) (Fig. 4). SDF-1-mRFP1-containing vesicles also
colocalized with the protein bassoon, which is a marker for active zones of transmitter release
from nerve terminals (Schoch and Gundelfinger, 2006) (Fig. 4). We also prepared cultures of
DG granule cells from SDF-1-mRFP1 transgenic mice. Cells in these cultures displayed many
SDF-1-mRFP1-containing vesicles. Depolarization of these cultured neurons with 50 mM K
produced a large increase in SDF-1 released into the culture medium (supplemental Fig. 2d,
available at www.jneurosci.org as supplemental material). Hence, it is clear that SDF-1-
mRFP1-containing vesicles in the DG include a population of nerve terminal associated
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synaptic vesicles and that these can be released by depolarization, a characteristic feature of
such vesicles.
Previous studies have demonstrated that neural stem cells in the adult DG express both nestin
and GFAP and have the characteristics of radial glia (Kempermann et al., 2004; Zhao et al.,
2006). Rapidly dividing neural progenitors (“transiently amplifying cells”) are derived from
these stem cells by a process of asymmetric division (Seri et al., 2004). Neural progenitors then
develop into granule cells by traversing a well described series of developmental steps
(Kempermann et al., 2004; Zhao et al., 2006). Both radial glia like cells (sometimes called type
1 cells) and their immediate progeny (sometimes called type 2 cells or rapidly amplifying cells)
are labeled in nestin-EGFP reporter mice (Tozuka et al., 2005). The observations discussed
above suggested that, as in the development of the DG, SDF-1 might play a role in the
development of granule cells in the mature DG. We therefore examined the effects of SDF-1
on neural progenitor cell function by directly recording from these cells. Type 1 and type 2
cells can be readily distinguished based on their different morphologies (Fig. 1c) and
electrophysiological properties. As reported by others, type 1 cells exhibited the electrical
properties of glia having a low membrane resistance (Filippov et al., 2003; Tozuka et al.,
2005). These cells were also generally unresponsive to the addition of GABAergic or
glutamatergic receptor agonists (data not shown). However the properties of type 2 cells were
very different (Fig. 5, Fig.6). These cells had high resistance and many cells responded to
agonists for GABAa or AMPA receptors. It has been demonstrated that GABAergic inputs to
neural stem cells develop before glutamate mediated inputs (Represa and Ben-Ari, 2005;
Tozuka et al., 2005; Ge et al., 2006; Bordey, 2007). Interestingly, these GABAergic inputs
initially take the form of a tonic GABA mediated current, which is followed developmentally
by phasic GABAergic synaptic transmission (PSC) (Bordey, 2007; Ge et al., 2007). In keeping
with these data, recordings from type 2 cells revealed that many cells exhibited an outward
current in response to addition of the GABAA receptor antagonist bicuculline. Other cells
exhibited phasic GABAergic currents, and many cells exhibited both types of GABAergic
currents (Fig. 5a). When SDF-1 was applied during recordings from type 2 cells, it regularly
produced a long-lasting inward current (Fig. 5b–d). SDF-1 produced no discernable effects on
type 1 cells. The SDF-1-induced inward current was completely reversed by bicuculline and
no SDF-1 induced current could be observed in cells pretreated with bicuculline, suggesting
that the effects of SDF-1 were mediated by activation of GABAA receptors (Fig. 5g). In
addition, SDF-1 increased both the frequency and amplitude of GABAergic PSCs (Fig. 5h,i).
We also examined the effects of SDF-1 in the presence of either TTX or Cd (Fig. 5e,f,i),
blockers of voltage-dependent Na and Ca channels, respectively. The effects of SDF-1 on the
tonic and phasic aspects of the current were still observed under these conditions. These data
suggest that SDF-1 may normally regulate GABAergic inputs to DG neural progenitors.
However, is SDF-1 normally released by neurons in the vicinity of neural progenitors? To test
this idea, we added the CXCR4 antagonist AMD3100 which, like bicuculline, regularly
produced an outward current when recording from type 2 cells (Fig. 6a). SDF-1 was ineffective
in cells pretreated with AMD3100 (Fig. 6i). Interestingly, the presence of the AMD3100
mediated current virtually completely occluded the effects of subsequently added bicuculline
and the effects of bicuculline occluded the effects of subsequently added AMD3100.
AMD3100 also reduced the frequency and amplitude of phasic GABAergic PSCs (Fig. 6g,h).
Hence, we conclude that GABA and SDF-1 are both tonically released and produce
GABAergic currents in type 2 cells. Because GABA and SDF-1 are both stored in the terminals
of GABAergic interneurons, we hypothesize that these molecules are coreleased and cooperate
in producing GABAergic transmission. Because basket cells do not express CXCR4 receptors
(supplemental Fig. 2a, available at www. jneurosci.org as supplemental material), we further
hypothesize that the effects of SDF-1/GABA are mediated postsynaptically, something that is
also consistent with the electrophysiological data. As a further test of this idea, we examined
the combined effects of SDF-1 and GABA added to type2 cells in whole-cell voltage-clamp
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recordings. We consistently observed that the effects of GABA were enhanced when it was
added in the presence of SDF-1 (supplemental Fig. 3a, available at www.jneurosci.org as
supplemental material).
As a comparison to the effects of SDF-1 on type 2 cells, we also performed similar
electrophysiological studies on DCX-EGFP-expressing cells from BAC reporter mice (Fig. 7).
The morphology of DCX-EGFP-expressing cells is much more heterogeneous than those of
nestin-EGFP-expressing cells (Tran et al., 2007) (Fig. 1d). We attempted to restrict our
recordings to cells with an immature morphology (i.e., round cells with minimal processes).
Here, again we observed effects of bicuculline, SDF-1, and AMD3100 on both phasic and tonic
currents (Fig. 7). However, a completely different picture was obtained when we recorded from
mature granule cells that did not express CXCR4-EGFP. Appropriately, SDF-1 did not produce
an inward current in these cells, although small bicuculline induced outward currents were
observed as previously reported in the literature (Glykys et al., 2008). In addition, AMD3100
did not produce an outward current in these recordings. Moreover, SDF-1 did not enhance the
size of GABAergic PSCs recorded in mature granule cells. In contrast, in the majority of these
cells, SDF-1 significantly decreased the magnitude of these PSCs (supplemental Fig. 3b,
available at www.jneurosci.org as supplemental material). SDF-1 was without effect when
added in the presence of AMD3100. These results suggest that the interaction between SDF-1
and GABAA signaling we have observed is developmentally regulated and only occurs during
early stages of granule cell development.
Discussion
The experiments described in this study suggest that the chemokine SDF-1 acts as a
neurotransmitter in the DG. The evidence supporting this supposition is similar to that available
for GABA, certainly a well-established neurotransmitter. Thus, both GABA and SDF-1 are
localized in synaptic vesicles within DG nerve terminals. Both GABA and SDF-1 produce
similar electrophysiological effects on nestin-EGFP and DCX-EGFP-expressing cells in the
SGZ. Moreover, it appears that both GABA and SDF-1 are tonically released in the DG. Thus,
addition of both GABAA and CXCR4 receptor blockers elicited an outward current, suggesting
that GABA and SDF-1 normally exert a tonic influence on type 2 progenitor cells. It also
appears that the effects of GABA and SDF-1 are linked in some way because the observed
effects of SDF-1 are sensitive to both GABAA and CXCR4 blockers.
SDF-1 and its receptor CXCR4 have been shown to be widely expressed throughout the
developing and adult nervous systems (Stumm et al., 2002; Banisadr et al., 2003; Tran and
Miller, 2003; Tran et al., 2007). Studies using null mice have highlighted the important role
that CXCR4 signaling plays during the development of the nervous system. CXCR4 signaling
has been shown to play two major roles during neuronal development. One is to act as a
chemotactic cue for the migration of neural stem/progenitor cells. Indeed, CXCR4 signaling
plays a similar role in the development of many tissues (Zou et al., 1998; Bagri et al., 2002;
Lu et al., 2002; Li and Pleasure, 2005). A second role for CXCR4 signaling is in the regulation
of axonal pathfinding (Kreibich et al., 2004; Lieberam et al., 2005). However, less is known
about the role of SDF-1/CXCR4 in the adult nervous system. SDF-1 has frequently been
observed to be constitutively expressed by neurons in the mature brain (Banisadr et al.,
2003), and it has been shown to produce effects on neuronal excitability and transmitter release
(Guyon and Nahon, 2007). Observations of this type have suggested that SDF-1 may normally
play a role in the regulation of synaptic communication, although whether SDF-1 is stored in
and released from neurons has not been demonstrated. The idea that SDF-1 and other
chemokines might act as neurotransmitters is supported by several observations in the literature
(de Jong et al., 2005; Fryer et al., 2006; Rostène et al., 2007; Jung et al., 2008). For example,
we have observed that, in association with the development of neuropathic pain, expression of
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the chemokine MCP-1 is upregulated by DRG neurons (Jung et al., 2008). MCP-1 is packaged
into the same synaptic vesicles as the neuropeptide CGRP and can be released from these
neurons by depolarization in a Ca-dependent manner (Jung et al., 2008). It may therefore be
the case that expression of chemokines by neurons is associated with a neurotransmitter role
for these molecules. SDF-1 is unusual, however, because it is constitutively expressed in
neurons, whereas other chemokines are usually upregulated in response to some pathological
event. Hence, it is likely that SDF-1/CXCR4 signaling is primarily concerned with the
regulation of events in addition to those associated with immunity.
In the experiments reported here, we used a new transgenic mouse model to examine the
physiological role of SDF-1 in the DG. We observed that SDF-1-mRFP1 was localized to
vesicles in neurons in many parts of the brain (Jung and Miller, unpublished observations) and
this distribution pattern was consistent with previous studies on the localization of SDF-1
(Stumm et al., 2002; Banisadr et al., 2003; Miller et al., 2005). The precise nature of the
neuronal vesicles that store SDF-1 is not known. Indeed, despite the fact that some studies have
demonstrated the storage of certain chemokines in secretory vesicles in leukocytes (Øynebråten
et al., 2004), no studies have investigated the storage pattern for SDF-1 in leukocytes or any
other type of cell. In the postnatal DG, we observed that SDF-1-mRFP1was expressed in
vesicles by both neurons and endothelial cells associated with blood vessels. SDF-1-mRFP1-
containing vesicles also expressed a number of proteins known to be associated with
neurotransmitter secretory vesicles. Moreover, SDF-1 could be released from granule cells by
depolarization. Hence, our conclusion is that SDF-1 is normally stored in a population of
synaptic neurotransmitter vesicles in the DG.
Based on the results of experiments examining its cellular and subcellular localization, as well
as its electrophysiological effects, SDF-1 appears to act as a neurotransmitter that is released
together with GABA from inhibitory interneurons and which co-operates with GABA in
communicating with neural progenitor cells. It is not known exactly how SDF-1 potentiates
GABAergic transmission. However, our experiments suggest that the observed interaction
occurs postsynaptically. Thus, effects of SDF-1 could be observed in the presence of TTX or
Cd, and synergistic effects between SDF-1 and GABA were observed in voltage clamp studies
using EGFP-expressing type 2 progenitor cells. Moreover, CXCR4 is not expressed by basket
cells, the likely presynaptic source of SDF-1 and GABA release. Numerous intracellular
signaling pathways have been shown to regulate GABAA receptors (Song and Messing,
2005; Houston and Smart, 2006). Hence, it is possible that activation of CXCR4 receptors
expressed by neural progenitors is able to transactivate GABAA receptors expressed by the
same cells. It is clear from our data that SDF-1 has an important influence on the effects of
GABA because inhibition of CXCR4 receptors often completely occluded any subsequent
effects of bicuculline. It is quite possible that the influence of SDF-1 is not constant and that
the levels of SDF-1 or of CXCR4 receptors may themselves be subject to regulation leading
to a context-dependent effect on GABAergic transmission.
It is apparent that the extent of DG neurogenesis in the adult is subject to the influence of
numerous factors (Sohur et al., 2006). It is thought that mechanisms must exist by which
activity in the granule cell layer can communicate with the pool of developing neural
progenitors so that neurogenesis can be regulated in keeping with the precise requirements of
the DG (Deisseroth and Malenka, 2005). Indeed, it is clear that changes in neuronal activity in
the DG can alter neurogenesis in the context of both normal physiology and pathology
(Scharfman and Hen, 2007). Exactly how this feedback mechanism is achieved has not been
completely understood. However, recent studies have indicated a role for GABAergic
transmission and GABAergic inputs to DG neural progenitors have been previously identified
(Ge et al., 2006). One possible source are immature granule cells that pass through a
GABAergic phase during their development (Gutiérrez, 2003). Another possibility is that the
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GABA is derived from a type of DG interneuron (Tozuka et al., 2005). Our studies support
this possibility, as we observed the terminals of parvalbumin-expressing GABAergic
interneurons in close proximity to dividing neural progenitors. Thus, it is likely that neuronal
activity in the granule cell layer can regulate the proliferation and differentiation of DG neural
progenitors through synaptic connections with basket cells which release GABA and SDF-1
(Deisseroth and Malenka, 2005; Tozuka et al., 2005). As we have now demonstrated,
GABAergic transmission to type 2 cells can be regulated by SDF-1, which is also tonically
released, raising the possibility that this chemokine plays a role in regulating the same stages
of granule cell development. SDF-1 produced similar effects on nestin-EGFP and DCX-EGFP
cells. Although this cell population is certainly heterogeneous (Steiner et al. 2006), it does
contain the “transiently amplifying population” whose proliferation may be susceptible to
external influences. It should be noted that CXCR4 is expressed by SGZ neural progenitor cells
from the earliest stages of development (Tran et al., 2007). Thus, CXCR4 is also expressed in
type 1 cells that express GFAP and nestin. Cells at this stage do not receive tonic GABAergic
inputs (Tozuka et al., 2005; Wang et al., 2005; Ge et al., 2006). Nevertheless, it remains possible
that CXCR4 signaling plays another type of role at this point. Furthermore, CXCR4 is also
expressed by immature granule cells that express calretinin, although not by mature granule
cells that express calbindin (Tran et al., 2007). Hence, it is possible that CXCR4 regulates other
steps in granule cell development as well (Pujol et al., 2005).
Neural stem cells in the brain under normal or pathophysiological conditions are thought to
reside in niche like structures which are susceptible to both neuronal and blood born influences
(Palmer et al., 2000; Ohab et al., 2006). It is therefore interesting to note that, in addition to
neurons, SDF-1 in the DG was expressed in endothelial cells associated with blood vessels
(Fig. 2, supplemental Fig. 1f,g, available at www.jneurosci.org as supplemental material).
Thus, it is possible that SDF-1 released by endothelial cells as well as neurons may coordinate
vascular and neuronal influences on DG neural progenitor function. This role may extend to
the neurogenic response of the brain to injuries such as stroke (Ohab et al., 2006). Although
SDF-1 is expressed by DG basket cells, it is also clearly expressed by other types of neurons
throughout the DG and the rest of the hippocampus. It is therefore likely that influencing neural
stem cell function as described here is not the only way in which SDF-1 regulates neuronal
function throughout the hippocampus, something that is also suggested by other recent
publications (Kasiyanov et al., 2007; Parachikova and Cotman, 2007). As our experiments also
demonstrate, SDF-1 did not produce currents in mature granule cells which do not appear to
express CXCR4 receptors. However, we did observe that the GABAergic input to these cells
was reduced by SDF-1, presumably by a presynaptic mechanism. It seems likely, therefore,
that SDF-1 produces a number of electrophysiological effects in the DG and that these may be
determined by the developmental stage of the neuron involved.
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Refer to Web version on PubMed Central for supplementary material.
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Expression of SDF-1 and CXCR4 in the adult mouse dentate gyrus. a–d, CXCR4, SDF-1,
nestin, and DCX are all expressed in the dentate gyrus of EGFP BAC reporter mice (4 weeks).
In c, the arrowhead illustrates an example of a nestin-EGFP-expressing type 1 cell. Arrow
illustrates an example of a nestin-EGFP-expressing type 2 cell. e, f, RT-PCR analysis of CXC
chemokine receptor expression by FACS derived cells isolated from the DG of nestin-EGFP
(e) and DCX-EGFP (f ) transgenic BAC reporter mice. Note the robust CXCR4 expression in
both populations of cells. g, Colocalization of BrdU labeling (red, immunohistochemistry) with
CXCR4-EGFP-expressing cells (arrowheads) in the DG of CXCR4-EGFP BAC reporter mice
(4 weeks). Scale bars: a–d, g, 50µm; c, insets I, II, 20µm.
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SDF-1 is expressed in synaptic vesicles in the adult mouse dentate gyrus. a, SDF-1-mRFP1
expression in numerous vesicles like structures throughout the dentate gyrus from an SDF-1-
mRFP1 BAC transgenic mouse (4 weeks). The arrows show a blood vessel. The arrowheads
illustrate SDF-1-mRFP1-containing vesicles within the cell body of a basket cell. The asterisks
illustrate unlabeled cell bodies surrounded by SDF-1-mRFP1-containing synaptic vesicles.
GrDG, Granule cell layer of DG; PoDG, polymorphic layer of the DG. a′, The same section
stained with parvalbumin (pv).a″, Merged image.b, Confocal microscopy reveals expression
of SDF-1-mRFP1 in association with blood vessels (tomato lectin, green) in the DG. c,
Confocal microscopy reveals that SDF-1-mRFP1 is localized to vesicles within a pv-expressing
neuron (basket cell) in the DG. d, e, SDF-1-mRFP1-labeled nerve terminals (red puncta) are
localized in close proximity to dividing cells in the DG labeled by BrdU incorporation (d) and
Ki67 staining (e) (both green). Scale bars: a–a″, 20µm; b, c, 32µm; d, e, 10µm.
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SDF-1-mRFP1 is localized to GABAergic terminals in close proximity to neural progenitors
in the DG. a–c, SDF-1-mRFP/CXCR4-EGFP bitransgenic mice illustrate the presence of
SDF-1-mRFP/VGAT-positive nerve terminal vesicles in close juxtaposition to a CXCR4-
EGFP-expressing neural progenitor (arrow). d–f, SDF-1-mRFP/nestin-EGFP bitransgenic
mice illustrate the presence of SDF-1-mRFP/VGAT-positive nerve terminals close to a nestin-
EGFP-expressing type 2 neural progenitor (arrow). c, f, Serial optical sections of cells indicated
by a white arrow are in the right panels. Red arrows, Terminals just labeled for SDF-1; blue
arrows, VGAT only; pink arrows, both SDF-1/VGAT. Examples are from 4-week-old mice.
Scale bars: (in a, d) a–f, 20µm; c and f right panels, 8µm.
Bhattacharyya et al. Page 18














SDF-1-mRFP1 is localized to synaptic vesicles in nerve terminals in close proximity to
CXCR4-positive cells in SGZ. a–d, SDF-1-mRFP/CXCR4-EGFP bitransgenic mice illustrate
the presence of SDF-1-mRFP1 (red, red arrows) in presynaptic terminals (blue, blue arrows),
labeled by synaptotagmin (a), synaptoporin (b), SV2 (c), or bassoon (d), in close juxtaposition
to a CXCR4-EGFP-expressing neural progenitors (green). Colocalization of SDF-1-mRFP1
with other markers is indicated by the pink arrows. Colocalization is also illustrated in three
dimensions in each panel. Examples are from 4-week-old mice. Scale bars, 4µm. GrDG,
Granule cell layer of DG; PoDG, polymorphic layer of DG.
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SDF-1 enhances GABA mediated activation of neural progenitors in the dentate gyrus.
Recordings taken from type 2 nestin-EGFP-expressing cells in acutely isolated slices from
mouse DG are shown. a, Bicuculline (Bic; 100µM) inhibited PSCs and produced an outward
current. b–d, SDF-1 (40 nM) produced a long-lasting inward current (b), which was reversed
by bicuculline (c, d). e, f, The inward current produced by SDF-1 was also observed in the
presence of either TTX (0.5µM, e) or Cd (10µM, f ). g, SDF-1 was ineffective in cells that were
pretreated with bicuculline. h, i, SDF-1 increased both the frequency and amplitude of PSCs
recorded from type 2 cells (h) and this was also the case in the presence of TTX (i). In a–d, 30
of 42 cells examined exhibited an outward current in response to bicuculline and 49 of 69
exhibited an inward current in response to SDF-1. In addition, 7 of 12 cells exhibited an inward
current in response to SDF-1 in the presence of TTX and 5 of 9 did so in the presence of
Cd 2+. SDF-1 increased the frequency and amplitude of 14 of 20 cells examined, and in TTX,
6 of 12 cells. **p<0.01; ***p<0.001. Error bars indicate SEM.
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SDF-1 is tonically released in the adult mouse dentate gyrus. Recordings made from nestin-
EGFP-expressing type 2 cells in the DG. a, The CXCR4 antagonist AMD3100 (1µM) produced
an outward current. b–f, Outward currents produced by AMD3100 or bicuculline (b, c,
100µM) were not additive (d, e, f, n44 cells). g–i, SDF-1 increased and AMD3100 reduced the
frequency and amplitude of PSCs. These effects of AMD3100 were observed after treatment
with SDF-1 (g) or in its absence (h). **p<0.01; ***p<0.001. i, SDF-1 was unable to produce
an effect in the presence of AMD3100, but did so after washout of the antagonist. Error bars
indicate SEM.
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Effects of SDF-1 on GABAergic inputs to DCX-EGFP-expressing cells in the adult mouse
dentate gyrus from DCX-EGFP BAC transgenic mice. a–d, SDF-1 (40 nM) increased the
amplitude and frequency of PSCs recorded in DCX-EGFP-expressing cells with immature
morphology and this was reversed by both bicuculline (a, b) and AMD3100 (c, d). SDF-1
produced this effect in 20 of 56 cells. This was reversed by bicuculline in five of seven cells
and by AMD3100 in three of five cells examined. **p<0.01; ***p<0.001. e, f, Both bicuculline
(3 of 4) and AMD3100 (3 of 5) produced an outward current in DCX-EGFP cells and their
effects were not additive. g, h, SDF-1 produced an inward current in DCX-EGFP cells and its
effects were reversed by bicuculline (g, 4 of 5) and by AMD3100 (h, 3 of 6). Error bars indicate
SEM.
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